Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice? - Wikidata - awgldk - TriplyDB

Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

http://www.wikidata.org/entity/Q33528966

about

Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.Practical use of the Framingham risk score in primary prevention: Canadian perspective Atherosclerosis in systemic lupus erythematosus.The effects of pre- and post-exercise consumption of multi-ingredient performance supplements on cardiovascular health and body fat in trained men after six weeks of resistance training: a stratified, randomized, double-blind study.Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.

P2860

Q33981152-1D89AD66-E329-44FA-BEA2-989AD2C0E1DA Q34791770-46BBBD47-7DBD-418B-BA98-561327FFB82A Q35525108-68A1F3A4-6C67-49AC-A586-129CD01520D5 Q36871083-C53B36DB-6E37-4616-AB6A-A9DF92A88A6A Q36974022-845A1B1E-EAA6-47E2-AA6E-6DDF8E3E311F

P2860

Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

http://www.wikidata.org/entity/Q33528966

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Measuring hsCRP--an important ...... clinically redundant practice?

@ast

Measuring hsCRP--an important ...... clinically redundant practice?

@en

Measuring hsCRP--an important ...... clinically redundant practice?

@nl

type

label

Measuring hsCRP--an important ...... clinically redundant practice?

@ast

Measuring hsCRP--an important ...... clinically redundant practice?

@en

Measuring hsCRP--an important ...... clinically redundant practice?

@nl

prefLabel

Measuring hsCRP--an important ...... clinically redundant practice?

@ast

Measuring hsCRP--an important ...... clinically redundant practice?

@en

Measuring hsCRP--an important ...... clinically redundant practice?

@nl

P1433

Q33528966-6A63FEEB-3230-4866-ADC1-48ACB0FC141B

P1476

Q33528966-B2BB5B9B-18CB-42E4-8D51-55CC773A8B6A

P2093

Q33528966-B66DF8C1-2370-46AF-97AE-DFC4BE71D816

Q33528966-BE91414E-35DF-4FE9-8213-358888ED391F

P2860

Q33528966-06A413E0-2C6B-41F0-85E2-1650C01C8BA8

Q33528966-0A852167-920B-49E6-9A64-5D01EF99D8ED

Q33528966-0EB137F9-799A-44A2-836F-4F28033CEE15

Q33528966-14B7774D-7449-4B50-ADDC-5850E7BE5B24

Q33528966-3560CE74-4E4D-454A-BCB2-FC2C77A8B11D

Q33528966-35F994FA-19A1-446F-8298-5404BF4C70E8

Q33528966-44424B40-CD36-4D1A-8AC3-9A49CA363C55

Q33528966-493DF6E1-CDAC-473A-AFD4-E5BB10EB0609

Q33528966-4A79AC29-D440-4F1C-9CEA-E3743180E462

Q33528966-4DD7D5FE-885B-4004-8CEE-C5067E8F30BD

P304

Q33528966-3707BA0D-9214-452B-8CC1-E8999C604324

P31

Q33528966-C6A63676-4A69-4E8E-AEED-02697BB627F3

P356

Q33528966-E1A3935C-7C72-4895-AE12-0B316B9708FB

P407

Q33528966-FF5B2ACF-7D9E-431E-8B23-9577B6C52D0A

P433

Q33528966-EA91AAF4-CCAD-49D8-ABBA-B20A8C866A89

P478

Q33528966-730E04D2-7ECE-413E-B7E9-906ABBE154B9

P577

Q33528966-C9D9BE0D-A3F3-416C-8A78-AE15FA41AE66

P5875

Q33528966-6974AE06-CA1D-4573-BBF8-830E2A77EA90

P698

Q33528966-D0533297-3AC7-4FED-804F-33EB90D01DE1

P932

Q33528966-5E8B7652-EFFB-47A9-8191-C7737293D79E

P356

JOURNAL.PMED.1000196

P1433

P1476

Measuring hsCRP--an important ...... clinically redundant practice?

@en

P2093

G Michael Allan

http://www.w3.org/2001/XMLSchema#string

James P McCormack

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes

C-reactive protein (CRP)-lowering agents

Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

P304

e1000196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1000196

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41401386

http://www.w3.org/2001/XMLSchema#string

P698

20126381

http://www.w3.org/2001/XMLSchema#string

P932

2814824

http://www.w3.org/2001/XMLSchema#string